Managing Irritable Bowel Syndrome–Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials
Clinical Gastroenterology and Hepatology · 2026-09
DOI: 10.1016/j.cgh.2026.09.022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Manjeet Kumar Goyal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Cleveland Clinic Akron General, Akron, Ohio. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND & AIMS: Persistent irritable bowel syndrome (IBS)-like symptoms affect up to one-third of patients with inflammatory bowel disease (IBD) in remission, representing a major unmet need not addressed by anti-inflammatory therapies. Despite increasing use of dietary and gut-brain-targeted strategies, their efficacy in this population remains uncertain. We performed a meta-analysis of randomized controlled trials (RCTs) to quantify the therapeutic effects of these interventions. METHODS: We systematically searched PubMed/MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Scopus, and ClinicalTrials.gov through October 2025 for RCTs enrolling adults with quiescent IBD and IBS-like symptoms. Interventions were synthesized according to intervention class (dietary, behavioral, pharmacologic, and other), with symptom severity and quality of life outcomes analyzed separately within each class. Standardized mean differences (SMDs) were pooled using random-effects models with Hartung-Knapp adjustment. The risk of bias was assessed using Cochrane Risk of Bias 2 and the certainty of evidence using Grading of Recommendations Assessment, Development, and Evaluation. RESULTS: Thirteen RCTs (n = 688) were included. Dietary interventions demonstrated the largest pooled symptom benefit (standardized mean difference [SMD], -1.33; 95% confidence interval, -4.42 to 1.77; I2 = 90%), although evidence was very low certainty because of heterogeneity and imprecision. Behavioral interventions showed a small treatment effect (SMD, -0.36; 95% confidence interval, -0.82 to 0.10; I2 = 0%) with low-certainty evidence. Evidence for pharmacologic and other interventions was limited to isolated, small trials. The risk of bias was high in 53.8% of studies, driven primarily by lack of blinding and subjective end points. CONCLUSIONS: The current evidence does not support a definitive benefit for any single intervention class in the management of IBS-like symptoms in quiescent IBD. Although dietary interventions demonstrated the largest point estimate for symptom improvement, the evidence remained highly uncertain because of imprecision and risk of bias. Larger, rigorously designed, blinded trials using standardized end points are needed to define effective symptom-directed therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Cleveland Clinic Akron General, Akron, Ohio.
- Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.
- Department of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, Maryland.
- Jerry M. Wallace School of Osteopathic Medicine, Campbell University, Lillington, North Carolina.
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India. Electronic address: dromeshgoyal@gmail.com.
- Cleveland Clinic Floyd D. Loop Alumni Library, Cleveland Clinic, Cleveland, Ohio.
Zitieren
APA
Goyal, M. K., Lee, A., Shah, D., Brehmer, S., Sheehan, J., Berinstein, J. A., Goyal, O., Nero, N. A., Singh, P., & Bishu, S. (2026). Managing Irritable Bowel Syndrome–Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.09.022
Vancouver
Goyal MK, Lee A, Shah D, Brehmer S, Sheehan J, Berinstein JA, et al. Managing Irritable Bowel Syndrome–Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.09.022
BibTeX
@article{Goyal2026,
author = {Goyal, Manjeet Kumar and Lee, Allen and Shah, Dhruvi and Brehmer, Samantha and Sheehan, Jessica and Berinstein, Jeffrey A and Goyal, Omesh and Nero, Neil A and Singh, Prashant and Bishu, Shrinivas},
title = {Managing Irritable Bowel Syndrome–Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.09.022}
}
EUVIMED